Methanol → HCID 22914494, compound
Reaction equation
[F:1][C:2]1[C:7]2[C:8](=[O:19])[N:9]([CH3:18])[CH2:10][C:11]3[N:12]([CH:13]=[N:14][C:15]=3[C:16]#[N:17])[C:6]=2[CH:5]=[CH:4][CH:3]=1.Cl.[NH2:21][OH:22].C[O-].[Na+].CO.[Na]>>[NH2:17]/[C:16](=[N:21]\[OH:22])/[C:15]1[N:14]=[CH:13][N:12]2[C:6]3[CH:5]=[CH:4][CH:3]=[C:2]([F:1])[C:7]=3[C:8](=[O:19])[N:9]([CH3:18])[CH2:10][C:11]=12Participants
6
Procedure
2 g (7.8 mmol) of 7-fluoro-5-methyl-6-oxo-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carbonitrile and 1.1 g (15.6 mmol) of hydroxylamine hydrochloride were added to a freshly prepared solution of sodium methylate in methanol (from 0.27 g (11.7 mmol) of sodium in 50 ml of methanol), whereupon the mixture was stirred at room temperature for 16 hours. Subsequently, the suspension was evaporated and treated with 100 ml of water. The precipitate obtained was filtered off and dried in a high vacuum. There were obtained 2 g (89%) of (E)-and/or (Z)-3-(amino-hydroxyimino-methyl)-7-fluoro-5-methyl-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepin-6-one as a colourless foam, Rf=0.25 (silica gel, methylene chloride/methanol 9:1).
Workup
- customSubsequently, the suspension was evaporated
- additiontreated with 100 ml of water
- customThe precipitate obtained
- filtrationwas filtered off
- customdried in a high vacuum
Sources & evidence
- ORD record
- ord-9f693a636aee413e8012746f03d8d0ac
- Source dataset
- uspto-grants-1997_09
- Patent number
- US05665718
Reaction notes
Loading…